News

Investor Strategies and Insights on Humana's Options Activity

Investor Strategies and Insights on Humana's Options Activity

Understanding Humana's Recent Options Activity

Investors with substantial resources are increasingly focusing on Humana (NYSE: HUM), a trend that warrants close attention from market participants. Our analysis of the latest options activity reveals some remarkable movements, suggesting that significant developments could be on the horizon for this health insurance company.

Today's data indicates a striking number of options activities—specifically, 17 noteworthy transactions—caught the eyes of our analysts. This unusual activity piques interest in the market and implies potential adjustments in HUM stock's future performance.

Examining Investor Sentiment

The current sentiment among investors stands out. About 58% maintain a bullish outlook, while 35% are taking a bearish approach. In these trades, this sentiment translates to 8 put options valued at $417,304 and 9 call options totaling $508,503. The difference between these values suggests that the market anticipates a stronger upward movement for Humana.

Price Target Projections for Humana

By assessing the volume and open interest in Humana's options, it's evident that major investors are targeting a price range between $250.0 and $350.0 in the upcoming quarters. These projected price targets can aid smaller investors in refining their investment strategies.

Insights from Volume and Open Interest

The metrics associated with volume and open interest in these contracts are vital indicators within the options trading world. They not only demonstrate investor interest but also shed light on liquidity at different strike prices. Recent evaluations have highlighted variations in both call and put options for Humana within the previously mentioned price range over the last month.

Notable Options Trades

Here are some key observations from the trades tracked:

  • Symbol: HUM, Order Type: Call, Sentiment: Bullish, Trade Date: 10/18/24, Price: $18.0, Total Trade Price: $126.0K, Volume: 78
  • Symbol: HUM, Order Type: Call, Sentiment: Bearish, Trade Date: 11/15/24, Price: $11.2, Total Trade Price: $107.5K, Volume: 255
  • Symbol: HUM, Order Type: Put, Sentiment: Bearish, Trade Date: 06/20/25, Price: $53.65, Total Trade Price: $85.8K, Volume: 30
  • Symbol: HUM, Order Type: Put, Sentiment: Bullish, Trade Date: 01/17/25, Price: $28.6, Total Trade Price: $85.8K, Volume: 30
  • Symbol: HUM, Order Type: Put, Sentiment: Bearish, Trade Date: 10/18/24, Price: $5.4, Total Trade Price: $59.9K, Volume: 186

Overview of Humana

Humana is a leading player among private health insurers in the United States, especially recognized for its Medicare Advantage plans. The company has carved out a significant niche within government-sponsored programs. A considerable portion of its membership stems from individual and group Medicare Advantage, Medicaid, and military programs like Tricare. Additionally, Humana excels at providing standalone prescription drug plans for seniors enrolled in traditional Medicare.

As we dig deeper into Humana's status, we will also look at how it performs in the overall market.

Current Status of Humana

  • Currently, HUM is trading at $312.87 with a trading volume of 402,787, showing a slight gain of 0.03%.
  • The stock's RSI values suggest it might be oversold.
  • Investors can look forward to the next earnings report in just over a month.

Insights from Market Analysts

Lately, three market analysts have shared their evaluations of Humana, reaching a consensus target price of around $396.67. An analyst from RBC Capital maintains an Outperform rating with a price target set at $400. In contrast, an analyst from Cantor Fitzgerald has lowered their outlook to Neutral with a target of $395, reflecting some recent market concerns.

Being aware of unusual options activity is crucial for investors looking to stay ahead in the market. Engaging with these insights offers a solid foundation for understanding market dynamics and confidently making decisions regarding Humana's stock.

Frequently Asked Questions

What does the recent options activity for Humana signify?

This activity suggests a bullish sentiment among investors, indicating expectations for significant price movements in Humana's stock.

How many options trades were highlighted in the recent analysis?

A total of seventeen unusual options activities were identified, reflecting increased interest in Humana's trading performance.

What is open interest in options trading?

Open interest refers to the total number of outstanding options contracts, providing insight into market liquidity and investor engagement.

What is the current price target set by analysts for Humana?

The analysts have established a consensus price target of about $396.67 for Humana.

What risks are associated with options trading?

Risks in options trading arise from market volatility and emphasize the need for ongoing education and strategic adjustments to weather these challenges.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading

Top 5 Most Recently Viewed Articles

Evaluating Chipotle Investment Prospects Amid Analyst Ratings

Updated Category News Views 57

Understanding Analyst Recommendations for Chipotle When it comes to making investment decisions, many investors tend to lean heavily on the advice from analysts. These recommendations can often sway market prices, prompting questions about their actual significance and reliability. Today, we aim to review insights regarding Chipotle Mexican Grill, represented on the stock...

Continue Reading
Lumicell's Trial Insights on Pegulicianine in Cancer Surgery

Updated Category News Views 121

Exciting Developments in Cancer Detection with Lumicell Pioneering real-time detection of cancer holds promise for a more complete resection in gastrointestinal surgery, facilitating better outcomes for patients. Breakthrough Trial Findings Lumicell, Inc., renowned for its innovative fluorescence-guided imaging technologies, presented promising findings from an ex vivo...

Continue Reading
BridgeBio Pharma's Growth Potential and Market Insights

Updated Category News Views 104

BridgeBio Pharma (NASDAQ: BBIO) made waves back in 2024 when Piper Sandler dropped its Overweight rating with a price target of $46.00. Traders took notice—could this company finally make strides in the tricky ATTR-CM landscape? ATTR-CM Market Insights: A Patient Population on the Rise? Mid-2024, findings from the Heart Failure Society of America hinted at around 58,000...

Continue Reading
Collective Mining Completes Major Investment and Warrant Exercise

Updated Category News Views 166

Collective Mining Strengthens Position with Strategic Investment Collective Mining Ltd. (NYSE: CNL) is excited to announce significant advancements following the recent investment by Agnico Eagle Mines Limited. This investment involves the subscription for approximately 4,741,984 common shares at a price of C$11.00 each, totaling around C$52.1 million. In addition, Agnico...

Continue Reading
GigaCloud Embraces Scott Living in Innovative BaaS Partnership

Updated Category News Views 134

GigaCloud Teams Up with Scott Living for a New Era GigaCloud Technology Inc. is thrilled to announce an exciting partnership with Scott Living by Drew & Jonathan, the well-known home furnishings brand established by the dynamic duo of renovation experts. This collaboration aims to redefine the landscape of goods available on the GigaCloud BaaS Marketplace, catering to a...

Continue Reading